Tag Archive for astrazeneca

Dentsply International reports record net sales for Q2

York-based Dentsply International reported record second entertain net sales Tuesday.

The company, a manufacturer of dental supplies, reported an gain boost of 25.2 percent to $763.0 million from $609.4 million in a second entertain of 2011.

Net sales, incompatible changed metals content, of $698.5 million increasing 23.8 percent from $564.0 million in a second entertain of 2011.

Overall gain continue to be increased by a new merger of Astra Tech, a Swedish provider of dental implants owned by AstraZeneca.

The $1.8 billion understanding was a largest in a company’s story

This quarter, net income attributable to Dentsply International alone for a second

Article source: http://www.ydr.com/business/ci_21198464/dentsply-international-reports-record-net-sales-q2

Dentsply to Buy AstraZeneca Dental Unit

AstraZeneca Plc arch executive officer David Brennan. Photographer: Andrey Rudakov/Bloomberg

Dentsply International Inc. (XRAY) agreed
to buy AstraZeneca Plc (AZN)’s Astra Tech unit, a Swedish manufacturer
of dental prosthetics and medical devices, for $1.8 billion to
become a world’s third-biggest builder of teeth implants.

The money transaction will be finished in a second half,
London-based AstraZeneca pronounced currently in a statement. Dentsply of
York, Pennsylvania, pronounced a squeeze will double the position
in dental implants, a marketplace whose annual expansion rate will
accelerate to 13 percent from 6 percent within

Article source: http://www.bloomberg.com/news/2011-06-21/astrazeneca-said-near-sale-of-unit-to-dentsply-for-1-8-billion.html?cmpid=yhoo

Recently expelled marketplace study: Migraine Global Clinical Trials Review, Q1, 2011

2011-02-28 06:11:07 – New Pharmaceuticals marketplace news from GlobalData: “Migraine Global Clinical Trials Review, Q1, 2011”

Migraine Global Clinical Trials Review, Q1, 2011


GlobalData’s clinical hearing report, “Migraine Global Clinical Trials Review, Q1, 2011″” provides information on a Migraine clinical hearing scenario. This news provides in-depth information and information relating to a clinical trials on Migraine. It includes an overview of a hearing numbers and their recruitment standing as per a site of hearing growth via a

world, focusing on a standing of appearance by a building nations.

Article source: http://www.pr-inside.com/recently-released-market-study-migraine-r2442998.htm